Revance Therapeutics Inc
RVNC·Stocks·Pharmaceuticals Major·United States·Nasdaq·USD
Price
$3.66
Today
+0.0%
YTD
+0.2%
About
Revance Therapeutics is a healthcare company based in Newark, California and listed on the NASDAQ GM under the ticker RVNC. Founded in 1999, the company operates globally, working on the creation of neuromodulators and covering the whole supply process. To see the RVNC price chart, add Revance Therapeutics to your watchlist.
Price chart
Closing price history for RVNC (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-1.90
P/S (TTM)1.54
P/B (TTM)-2.35
Market cap$381.02M
Cap tierSmall-cap
Industry avg P/E-43.36
Profitability
Gross margin70.15%
EBIT margin-67.21%
Net margin-63.65%
ROE-2096.78%
ROA-36.38%
Earnings & Revenue
Revenue (TTM)$247.00M
Revenue growth (1Y)+15.3%
EPS (TTM)-$1.92
Free cash flow$-194.91M
Total debt$483.45M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.32
Employees597
Next earnings27 Feb '25
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.